VRDN

NASDAQ HEALTHCARE

Viridian Therapeutics Inc

$23.98

$0.64 (+2.72%)

Live quote

52w: $13.18 – $34.29

Loading chart…

P/E Ratio—

P/B Ratio3.99

EV/EBITDA—

Debt/Equity—

ROE-51.74%

ROIC—

Revenue Growth23359.93%

Gross Margin—

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. The company is headquartered in Boulder, Colorado.

Own VRDN? Track it here.

Create a free account to add VRDN to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account